Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management
Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2025 financial guidance provided on 3Q25...
Cancer
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine...
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine...
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
AUSTIN, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: As late-stage biotech pipelines mature, fair-value remeasurements under U.S....
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued...
Persephone Biosciences Announces Positive Topline Results from ARTEMIS Clinical Trial of First-of-its-kind Synbiotic for Children
- 114 infants and toddlers received Persephone’s synbiotic or placebo - - The study generated important, positive clinical data on...
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1
Evaxion’s AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component...
NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference
BELTSVILLE, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
Syncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual Meeting
FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical company pioneering...
Konica Minolta Healthcare Reinforces Leadership in Advanced Radiography with Seven Scientific Presentations on Dynamic Digital Radiography at RSNA 2025
Dynamic Digital Radiography pulmonary Konica Minolta's IWS workstation processes and quantifies Dynamic Digital Radiography diaphragmatic motion data. WAYNE, N.J., Nov....
Oncotelic Achieves Breakthrough $1.7 Billion Pipeline Valuation Through GMP Bio Joint Venture
Independent valuation reflects major advancement of OT-101 and Deciparticle™ nanomedicine platformSAN DIEGO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- via IBN...
EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU
EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU AUSTIN, Texas, November 20, 2025 - EDAP...
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
Collaboration uses Receptor AI's platform to design highly selective anti-cancer kinase inhibitor products for BriaPro, a BriaCell subsidiaryPartnership expected to...
Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”),...
CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally
Curium and CapVest have announced the recapitalization of Curium via a new Continuation Vehicle The transaction values Curium at circa...
Can-Fite’s CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil
~35% of erectile dysfunction patients in a $3.2 billion market are non-responders to brands including Viagra and Cialis, and these...
BioNxt Secures Final Patent Grant from the Eurasian Patent Organization for Sublingual Cladribine Platform
VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...
Health Union Recognized for Unmatched Excellence in HCP and Patient Engagement, Earning 19 Awards
PHILADELPHIA, Nov. 19, 2025 /PRNewswire/ -- Health Union, the leading digital health company for online community-based activation and data, today announced...
Florida Holster Company Raises Over $10K for Local Breast Cancer Fighter After National Organizations Reject Donation
MOUNT DORA, Fla., Nov. 19, 2025 /PRNewswire/ -- When national breast cancer organizations turned them away, Florida-based Vedder Holsters found...
Canopy Study Selected for Oral Presentation at ASH 2025
Study shows potential of Canopy 's Remote Therapeutic Monitoring Platform to reduce infection-related hospitalizations and ER visits in patients treated...